Gram-Positive, FDA Cleared

Gram-Positive Cocci

The iCubate iC-GPC Assay™ is a multiplexed, in vitro diagnostic test for the rapid detection and identification of potentially pathogenic gram positive bacteria, which may cause bloodstream infection (BSI).  Traditional culture techniques may require 2-4 days to identify both the causative organism and resistance profile, resulting in delayed treatment and increased costs.  The iC-GPC Assay™ provides bacterial identification and resistance determination from positive blood cultures up to 48 hours faster than conventional methods, improving time to treatment and patient outcomes. The iC-GPC Assay™ detects five of the most common gram positive organisms associated with BSI as well as three clinically significant resistance markers:

Bacterial Species Resistance Markers
Staphylococcus aureus

Staphylococcus epidermidis

Streptococcus pneumoniae

Enterococcus faecalis

Enterococcus faecium

mecA– associated with methicillin resistance

vanA- associated with vancomycin resistance

vanB– associated with vancomycin resistance

FDA Cleared

The iCubate® system is the cost-effective molecular diagnostic solution providing clinical microbiology labs rapid syndromic testing for infectious diseases, leading to better care sooner.

Subscribe to Newsletter

Join the iCubate community for the latest updates!